Lunai Bioworks Expands CNS Platform with $20 Million IP Acquisition to Advance Alzheimer’s and Neurotherapeutic Programs

Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505(b)(2) Pathways, and CNS Countermeasure Applicati...

May 06, 2026 | Wednesday | News
FreeMind Investments and Daewoong Pharmaceutical Invest in General Proximity to Advance Induced Proximity Therapeutics

FreeMind Investments (FMI), a venture capital fund launched in partnership between FreeMind Group and Daewoong Pharmaceutical Co., Ltd., announced its in...

May 06, 2026 | Wednesday | News
UCB to Acquire Candid Therapeutics in Up to $2.2 Billion Deal to Expand Next-Generation Immunology Portfolio

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for i...

May 05, 2026 | Tuesday | News
Thermo Fisher Scientific to Divest Microbiology Unit to Astorg in $1.075 Billion Deal

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiol...

April 29, 2026 | Wednesday | News
Sun Pharmaceutical Industries Limited to Acquire Organon & Co. in $11.75 Billion Deal to Expand Global Women’s Health and Biosimilars Footprint

Sun Pharmaceutical Industries Limitedand Organon & Co. announced that they have entered into a definitive agreement under which Sun Pharma will acqui...

April 29, 2026 | Wednesday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
Servier Completes $2.5B Acquisition of Day One Biopharmaceuticals, Bolstering Rare Cancer Pipeline with OJEMDA

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade gl...

April 27, 2026 | Monday | News
10x Science Raises $4.8M Seed to Transform Molecular Protein Characterization with Explainable AI

10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed ...

April 24, 2026 | Friday | News
Nxera Pharma Secures Third R&D Milestone in Neurology Collaboration with AbbVie

This marks the third milestone achieved under the collaboration and reflects the steady progress of the pipeline Under the terms of the agreement, Nxe...

April 21, 2026 | Tuesday | News
Samsung Biologics Secures GSK Site in $Capacity Boost to 845,000L

  Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics’ geographical diversific...

April 01, 2026 | Wednesday | News
Biogen to Acquire Apellis in $5.6B Deal to Strengthen Immunology and Rare Disease Portfolio

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including...

April 01, 2026 | Wednesday | News
Stratum Biosciences Secures $2M Seed Funding to Advance AI-Driven Skin Biology Discovery

  Stratum Biosciences, a biotechnology pioneer at the intersection of artificial intelligence and dermatology research, announced the closing of a $2...

March 30, 2026 | Monday | News
Novartis to Acquire Excellergy in Up to $2 Billion Deal to Advance Next-Generation Allergy Therapies

Acquisition brings together Excellergy's differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise o...

March 30, 2026 | Monday | News
Emergent BioSolutions Secures $54M U.S. Contract and Expands Global Orders for Smallpox Countermeasures

Emergent BioSolutions Inc. announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Glo...

March 27, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close